News Focus
News Focus
icon url

StocksDiva

10/22/12 7:10 AM

#9617 RE: StocksDiva #9616

Delcath Systems (DCTH)announced that it has satisfied all of the requirements to affix the CE Mark to its Hepatic CHEMOSAT Delivery System for use with doxorubicin hydrochloride injection.

http://finance.yahoo.com/news/delcath-announces-ce-marking-hepatic-103101254.html